New diagnostic and therapeutic tools
against multidrug resistant tumours

ITC Conference Grantees

III International AICC Exosome meeting Cell to cell delivery in cancer and therapy: a matter of carriers and messages

Italy (online) 07.06.2021 – 08.06.2021

Dr. Hugo R. Caires and Dr. Diana Sousa, from the IPATIMUP, Institute of Molecular Pathology and Immunology – University of Porto (Portugal) were awarded an ITC Conference Grant to attend the III International AICC Exosome meeting Cell to cell delivery in cancer and therapy: a matter of carriers and messages. At the meeting, dr. Caires presented his research results in the flash presentation entitled Analysing leukaemia-derived EVs in the peripheral blood of Acute Myeloid Leukaemia patients: a reliable source of residual disease biomarkers? Dr. Sousa presented her work in the flash presentation entitled Next generation sequencing analysis reveals distinct transcripts and microRNAs in tumor multidrug resistant cells and extracellular vesicles when compared with their drug-sensitive counterparts. The presentation of both Dr. Caires and Dr. Sousa were awarded as the best flash presentations of the AICC meeting. Both Dr. Caires and Dr. Sousa are part of the research group of Prof. Helena Vasconcelos(Core Group MemberMC MemberWG3 Leader).

 

UPCON Conference (Conference on Properties, Design, and Applications of Upconversion Nanomaterials

France (online) 6.4.2021 – 9.4.2021

Dr. Verónica Bastos, from the University of Aveiro (Portugal) was awarded an ITC Conference Grant to attend the UPCON Conference (Conference on Properties, Design, and Applications of Upconversion Nanomaterials. At the meeting, she presented her research results in the poster entitled Melanoma chemotherapy with doxorubicin loaded upconversion nanoparticles. Dr. Bastos is member of the working group 2: “Synthesis and nanodelivery stratagies for new therapeutic tools against MDR tumours” and also working group 3: “Efficacy validation of new therapeutic tools against pre-clinical models of MDR tumours”.

 

 

 

 

EACR-AACR-ASPIC ‘Basic and Translational Research Conference Tumor Microenvironment’

Portugal 2.3.2020 – 4.3.2020

Dr Tijana Stankovic, from the Instute for Biological Research “Sinisa Stankovic”, University of Belgrade (Belgrade) was awarded an ITC Conference Grant to attend the EACR-AACR-ASPIC ‘Basic and Translational Research Conference Tumor Microenvironment’.

Dr. Stankovic is member of the working group 3: “Efficacy validation of new therapeutic tools against pre-clinical models of MDR tumours”.

 

5th GEIVEX Symposium

Granada 6.11.2019 – 8.11.2019

Dr. Diana Sousa, from the IPATIMUP, Institute of Molecular Pathology and Immunology – University of Porto (Portugal) was awarded an ITC Conference Grant to attend the 5th GEIVEX Symposium. At the meeting, she presented her research results in the poster entitled Distinct regulation of the endocytic pathway between drug-sensitive and multidrug resistant cancer cells may influence their ability to release and capture EVs. Dr. Sousa is part of the research group of Prof. Helena Vasconcelos (Core Group Member, MC Member, WG3 Leader).

 

2nd EURASIA Biochemical Approaches and Technologies Congress (EBAT)

Antalya 26.10.2019 – 29.10.2019

Simona Dobiasova, from the University of Chemistry and Technology in Prague (Czechia) was awarded an ITC Conference Grant to attend the 2nd EURASIA Biochemical Approaches and Technologies Congress. At the meeting, she presented her research results in the poster entitled Modulation Of P-Glycoprotein Activity By Flavonolignans. Simona Dobiasova is part of the research group of Dr. Jitka Viktorova (MC Member, WG3).

 

 

 

 

 

 

Natural Products in Drug Discovery and Human Health

Lisbon 28.07.2019 – 31.07.2019

Dr. Una Glamoclija, from the International University of Sarajevo (Bosnia and Herzegovina) was awarded an ITC Conference Grant to attend the Natural Products in Drug Discovery and Human Health conference. At the meeting, Dr. Glamoclija presented her research results in the poster entitled Hormetic effects of thymoquinone in leukemia and lymphoma cells . Dr. Glamoclija is part of the research group of Prof. Mirza Suljagic (MC SubstituteWG1WG3).